Cleared Traditional

K012319 - RANDOX HUMAN ASSSAYED DRUG CONTROL

K012319 is the FDA 510(k) clearance for RANDOX HUMAN ASSSAYED DRUG CONTROL by Randox Laboratories, Ltd.. It is a Class 1 Chemistry device (product code DIF) cleared through the Traditional 510(k) pathway after a 32-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2001
Decision
32d
Days
Class 1
Risk

K012319 is an FDA 510(k) clearance for the RANDOX HUMAN ASSSAYED DRUG CONTROL. Classified as Drug Mixture Control Materials (product code DIF), Class I - General Controls.

Submitted by Randox Laboratories, Ltd. (Crumlin, Co. Antrim, GB). The FDA issued a Cleared decision on August 24, 2001 after a review of 32 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.3280 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Randox Laboratories, Ltd. devices

Submission Details

510(k) Number K012319 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 23, 2001
Decision Date August 24, 2001
Days to Decision 32 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 88d · This submission: 32d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code DIF Drug Mixture Control Materials
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.3280
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - DIF Drug Mixture Control Materials

All 146
Devices cleared under the same product code (DIF) and FDA review panel - the closest regulatory comparables to K012319.
TRIAGE TOX DRUG SCREEN CONTROLS, CATALOG #94001
K012999 · Biosite Incorporated · Oct 2001
TRIAGE TOX DRUG SCREEN CALIBRATION VERIFICATION CONTROLS, CATALOG #94002
K013002 · Biosite Incorporated · Oct 2001
LIQUICHEK TDM CONTROL
K012741 · Bio-Rad · Sep 2001
ONTRAK TESTCUP M2K AND ONTRAK TESTSTIK POSITIVE CONTROL, MODEL 11 18544, ONTRAK TESTCUP M2K AND ONTRAK TESTSTICK NEGATIV
K990377 · Roche Diagnostics Corp. · Feb 1999
SYNCHRON SYSTEMS DAT LOW AND HIGH URINE CONTROLS 1
K983709 · Beckman Coulter, Inc. · Oct 1998
ONTRAK TESTCUP AND TESTSTIK CONTROLS
K983387 · Roche Diagnostic Systems, Inc. · Oct 1998